Nanoemulsion Stability Testing: DLS Protocols for Sub-200 nm Cosmetic Delivery Systems

How Dynamic Light Scattering (DLS) analysis characterises nano-scale particle integrity across the NanoBase™ tri-domain nano-colloidal Architecture - and where conventional QC methods reach their limits at sub-micron resolution.

DOI Reference: 10.5281/zenodo.18616576

Why Nanoemulsion Stability Cannot Be Assessed Visually

Traditional emulsion stability testing relies on centrifugation, creaming indices, and visual turbidity assessment. These macroscale methods were designed for HLB-based emulsions with droplet diameters of 1-50 µm. At the nano-scale (≤200 nm), Brownian motion dominates over gravitational separation, making centrifugal and visual methods less informative.

NanoBase™ is engineered to a ~185 nm design target, DLS-characterised every batch. At this scale, the key stability metric is time-resolved Dynamic Light Scattering (DLS).

Dynamic Light Scattering: Principle and Protocol

DLS measures the Brownian motion of suspended nanoparticles by analyzing the autocorrelation function of scattered laser light (typically 633 nm, He-Ne). The hydrodynamic diameter is calculated via the Stokes-Einstein equation, where the translational diffusion coefficient derived from autocorrelation decay is inversely proportional to particle size through solvent viscosity and absolute temperature.

Standard Protocol for NanoBase™ QC

Instrument: calibrated DLS particle size analyser. Temperature: 25.0 ± 0.1 degrees C, equilibrated 120 seconds. Dilution: 1:100 in deionized water to eliminate multiple scattering. Measurement: Minimum 3 runs, 12 sub-runs each. Acceptance criteria: Z-average within the batch specification around the ~185 nm design target.

Tri-Domain Stability: Three Carriers, Three Failure Modes

NanoBase™ tri-domain architecture combines nanocolloidal, nanoliposomal, and nanomicellar domains in a single formulation matrix. Each domain exhibits distinct degradation kinetics that DLS uniquely detects.

The nanocolloidal domain (oil-in-water, designed to an electrostatic (DLVO) stabilisation specification) is susceptible to Ostwald ripening, which can show up as Z-average drift (for example, more than 5 nm per month). The nanoliposomal domain (phospholipid bilayer) can undergo bilayer fusion, which can show up as a second peak emerging (for example, above 400 nm). The nanomicellar domain can disassemble if diluted below its CMC, which can show up as a sharp PDI rise with a simultaneous count rate drop.

Accelerated stability testing at 40 ± 2 degrees C and 75 ± 5% RH per ICH Q1A(R2) guidelines, with DLS measurements at T0, T30, T60, and T90 days, captures all three degradation pathways simultaneously.

Why PDI Matters More Than Mean Particle Size

Polydispersity index quantifies the breadth of the particle size distribution. A low PDI indicates a narrow distribution; a high PDI indicates the broad distributions often seen in conventional emulsions. NanoBase™ is DLS-characterised every batch, including its size distribution.

DLS vs Conventional QC Methods

Visual assessment resolves only above 10 µm and cannot measure PDI. Optical microscopy resolves above 1 µm. Laser diffraction covers 100 nm to 3 mm but offers only marginal nano-applicability with span measurement only. DLS resolves 0.3 nm to 10 µm with full PDI measurement capability. Nanoparticle Tracking Analysis (NTA) covers 10 to 2000 nm with histogram-based size distribution.

Implications for Brand Partners

Every NanoBase™ batch shipped by Pensive Beauty includes a Certificate of Analysis (CoA) with DLS-characterised Z-average and intensity-weighted size distribution. This level of analytical documentation is uncommon in conventional cosmetic contract manufacturing.

For formulation chemists and brand founders evaluating contract manufacturers, the presence or absence of DLS-based QC is a useful indicator of nanoscale manufacturing.

Technical data reference: Pensive Beauty Nanoscience Labs. Replacing Traditional Hydrophilic–Lipophilic Balance Systems with a First-in-Class Tri-Domain Delivery Platform: NanoBase™ (Zenodo technical note, not peer reviewed). Zenodo, 2026. DOI: 10.5281/zenodo.18616576

Previous
Previous

Particle Size Uniformity in Nanocosmetic Manufacturing: What a Multi-Angle DLS Signature Shows

Next
Next

How to Start a Skincare Line: A Complete Guide for 2026